Cure My Disease

Don't miss your cure!

 Log in / Sign up

New scan could replace needle biopsies for liver disease

NCT ID NCT07440511

Recruiting now Diagnosis Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Apr 02, 2026 · Last updated Apr 15, 2026 · Updated 2 times

Summary

This study is testing a new, non-invasive scanning method that measures spleen stiffness to better detect and monitor advanced liver scarring in people with fatty liver disease (MASLD). Researchers will follow 500 adult patients with confirmed or suspected advanced liver disease to see if this scan can accurately predict serious liver complications over time. The goal is to find a safer, easier alternative to invasive liver biopsies for tracking disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione Policlinico Universitario A. Gemelli IRCCS

    RECRUITING

    Rome, 00168, Italy

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)